-

02:17:50 PM

TELA Stock News

TELA - TELA Bio Inc

09/18/23 4:05 PM

Nasdaq : TELA

conferencesacquisitionlow float

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own

RHEA-AI

neutral

08/16/23 7:00 AM

Nasdaq : TELA

low float

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes

RHEA-AI

neutral

08/09/23 4:03 PM

Nasdaq : TELA

earningslow float

TELA Bio Reports Second Quarter 2023 Financial Results

TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own

RHEA-AI

neutral

08/04/23 4:02 PM

Nasdaq : TELA

low float

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the

RHEA-AI

very positive

07/26/23 7:00 AM

Nasdaq : TELA

earningslow float

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the

RHEA-AI

neutral

06/15/23 7:00 AM

Nasdaq : TELA

low float

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

TELA Bio, Inc . (NASDAQ: TELA), a

RHEA-AI

neutral

05/25/23 7:00 AM

Nasdaq : TELA

conferenceslow float

TELA Bio to Participate in the Jefferies Global Healthcare Conference

TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy,

RHEA-AI

neutral

05/19/23 7:00 AM

Nasdaq : TELA

low float

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by

RHEA-AI

neutral

05/11/23 4:02 PM

Nasdaq : TELA

earningslow float

TELA Bio Reports First Quarter 2023 Financial Results

TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own

RHEA-AI

neutral

05/08/23 4:30 PM

Nasdaq : TELA

low float

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the

RHEA-AI

very positive

1 2 3 4 5 6 7 8 9 10 Next

TELA Data

IndustrySurgical and Medical Instrument Manufacturing
Websitetelabio.com
Security nameTELA Bio Inc
SectorManufacturing
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing

About TELA Bio Inc

tela bio, inc., a surgical reconstruction company, was created out of the desire to do things differently. combining the drive and innovation of a start-up with a seasoned medical technology team, the company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair. based in malvern, pennsylvania, this science-driven company is collaborating with leading surgeons to reinvigorate the soft tissue reconstruction market and bring cost-effective solutions to hospitals, surgeons and patients. please see our social media community guidelines at http://bit.ly/1uvcx0l